Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.
Q3 Preview: Pfizer (PFE) Chugging Strong Into Earnings; M&A and Pipeline Key Focal Points (MRK, NVS)
-
Morning Movers 01/04: BFRM, DPTR, CDII, KNDI Higher; MELI, EAT, ACL Lower
-
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
-
Deutsche Bank Initiates Coverage on Novartis (NVS) with a Buy
-
Notable Analyst Rating Changes 9/11: NVS, TSN, ALB Upgraded; LEH, NVDA, RAI, KNXA Downgraded
-
Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News
-
Deutsche Bank Downgrades Novartis (NVS) to Hold
-
Unusual 11 Mid-Day Movers 2/29: MNTA, JRJC, SAPE, COMS Higher; FMT, CDL, RHD, ABH Lower
